|
PTP’s Health Physics Courses - the best in hands-on radiation safety training
|
|
>
By Subject >Nuclear
Medicine 
|
|
|
Number
|
|
Title
|
|
NRC
|
Guide
|
|
Licensing Guide for Diagnostic Nuclear
Medicine
|
|
NRC
|
RegGuide 8.39
|
|
Release of Patients
Administered Radioactive Materials (Draft DG-8015 published 6/1994) (Errata
published 5/1997)
|
|
NRC
|
RegGuide 10.8
|
|
Guide for the Preparation of
Applications for Medical Use Programs (Draft FC 415-4, Proposed Revision 2,
published 8/1985) (Draft DG-0002, Proposed Appendix X to Regulatory Guide
10.8, published 12/1991) (Appendix X published June 1992) (DG-0009, Proposed
Supplement, published 3/1997)
|
|
NRC
|
NUREG 1516
|
|
Management of
Radioactive Material Safety Programs at Medical Facilities
|
|
NRC
|
NUREG 1556
|
|
Consolidated Guidance
About Materials Licenses: Vol.
9: "Program-Specific Guidance About Medical Use Licenses (Rev. 1. May
2005)
|
|
NRC
|
RIS 08-011
|
|
Precautions To Protect Children Who
May Come In Contact With Patients Released After Therapeutic Administration
Of Iodine-131
|
|
NRC
|
RIS 02-020
|
|
NRC Regulatory Issue
Summary 2002-20: Clarification of Requirements Under 10 CFR
35.432,"Calibration Measurements of Brachytherapy Sources"
|
|
NRC
|
RIS 02-019
|
|
New Modalities to be
Regulated under 10 CFR 35.1000 - NRC Regulatory Issue Summary 2002-19
|
|
NRC
|
RIS 02-006
|
|
Evaluating Occupational
Dose for Individuals Exposed to NRC-licensed Material and Medical X-rays -NRC Regulatory Issue Summary 2002-06:
|
|
NRC
|
HPPOS145
|
|
Authorized Users' Supervision of
Medical Programs
|
|
NRC
|
HPPOS262
|
|
Radioactive Drug Research
Committees
|
|
NRC
|
HPPOS270
|
|
Interpretation of 10 CFR
35.33(c) Regarding Diagnostic Misadministration Reporting Threshold Levels
|
|
NRC
|
HPPOS286
|
|
Angell Memorial Animal Hospital,
Boston, MA; Release to Unrestricted Area of Animals Containing Iodine-131
|
|
NRC
|
HPPOS313
|
|
Whether a Cardiologist Must be
Authorized by NRC to Interpret Nuclear Medicine Patient Scans, DePaul Hospital,
Cheyenne, WY
|
|
NRC
|
HPPOS319
|
|
Policy Guidance Concerning Use
of Xenon-133 in Saline
|
|
NRC
|
HPPOS320
|
|
Regarding Mediq Imaging, Inc.,
Providing Service to a Private Practice (Non-licensee) Located within a
Hospital
|
|
NRC
|
HPPOS321
|
|
Guidance on Setting Action
Levels for Exemption for Requirement to Decontaminate Therapy Room for
Unrestricted Use
|
|
NRC
|
In02028
|
|
Problems Involved in
Monitoring Dose to the Hands Resulting from the Handling of Radiopharmaceuticals
In03012
|
|
NRC
|
In02028
|
|
Appointment of Radiation Safety
Officers and Authorized Users Under 10 CFR Part 35
|
|
NRC
|
In02023
|
|
Unauthorized Administration of
Byproduct Material For Medical Use
|
|
NRC
|
In02019
|
|
Medical Misadministrations
Caused by Failure to Properly Perform Tests on Dose Calibrators for
Beta-and-Low Energy Photon-Emitting Radionuclides In02019
|
|
NRC
|
In02017
|
|
Medical use of Strontium-90
Eye Applicators: New Requirements for Calibration and Decay Correction
In02017
|
|
NRC
|
In02016
|
|
Intravascular Brachytherapy
Misadministrations In02016
|
|
NRC
|
In00005
|
|
Recent Medical
Misadministrations Resulting from Inattention to Detail
|
|
NRC
|
In94007
|
|
Radiopharmaceutical Vial
Breakage During Preparation
|
|
NRC
|
In94070
|
|
Issues Associated with Use of
Strontium-90 and Other Beta Emitting Radiopharmaceuticals
|
|
NRC
|
In93010
|
|
Dose Calibrator Quality
Control
|
|
NRC
|
In90059
|
|
Errors in the Use of
Radioactive Iodine-131
|
|
NRC
|
In90071
|
|
Effective Use of Radiation
Safety Committees to Exercise Control Over Medical Use Program
|
|
NRC
|
In89012
|
|
Dose Calibrator Quality
Control
|
|
NRC
|
In89074
|
|
Clarification of
Transportation Requirements Applicable to Return of Spent Radiopharmacy
Dosages From Users to Suppliers
|
|
NRC
|
In84085
|
|
Molybdenum Breakthrough From
Technetium-99m Generators
|
|
ORAU
|
NUREG 6345
|
|
A Compendium Of Dose Estimates
For Many Radiopharmaceuticals
|
|
ORAU
|
|
|
Radiation Dose Estimates To
Adults And Children From Various Radiopharmaceuticals
|
|
ORAU
|
|
|
Tables Of Radiation Absorbed
Dose To The Embryo/Fetus From Radiopharmaceuticals. See Health Physics (73[5]:756-769, 1997).
|
|
ORAU
|
|
|
Guidelines For Breastfeeding
Mothers In Nuclear Medicine
|
|
ORAU
|
|
|
Health Concerns Related to Radiation
Exposure of the Female Nuclear Medicine Patient
|
|
ORAU
|
|
|
Comparison of Effective Dose
Equivalent (ICRP 30), Effective Dose (ICRP 60), and Total Body Dose for 62
Radiopharmaceutical Procedures
|
|
|
NL-SA-18458
|
|
Contributions And Future
Of Radioisotopes In Medical, Industrial, And Space Applications
|
